Evaluation of the skin safety of a test product (sunscreen) for primary skin irritation using the skin irritation test (patch test in humans)
Cosmoderma · 03.04.2026 · 6 · 39
DOI: 10.25259/csdm_10_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmoderma, online erschienen am 03.04.2026. Verfasst von Monil Yogesh Gala und 4 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objectives
The objective of this study was to evaluate the primary skin irritation potential of Venusia Sun Unseen Sunscreen, using a standardized human patch test. Materials and Methods: This was a monocentric, non-randomized, evaluator-blinded, single-application, controlled study conducted in accordance with IS 4011:2018 guidelines. Healthy male and female volunteers (18– 65 years, Fitzpatrick skin type III-V), including 50% classified as having sensitive skin, were included in the study. Occlusive patches containing Venusia Sun Unseen Sunscreen (~0.04 g), 0.9% isotonic saline (negative control), and 1% sodium lauryl sulfate (SLS, positive control) were applied for 24 h. The patch was removed at 24 h, scores were recorded at 48 h, and a follow-up visit was conducted 1 week later to verify the recovery of subjects who experienced local reactions. Skin reactions were graded using the Draize scale.
Results
Twenty-six healthy adults (13 males, 13 females; mean age 30.88 ± 9.97 years), including 50% classified as having sensitive skin as identified by the lactic acid sting test, participated. All 26 participants completed the study. At 48 h, the sunscreen demonstrated a combined mean erythema/dryness/wrinkle plus edema score of 0.69, well below the IS 4011:2018 guidelines non-irritant threshold of 2.0. Saline produced no reaction (0.00), while SLS showed marked irritancy (3.04), validating assay sensitivity. No delayed reactions or adverse events were reported.
Conclusion
Venusia Sun Unseen Sunscreen was classified as non-irritant under standardized patch test conditions in both sensitive and normal skin populations. These findings support its dermatological safety and reinforce its suitability as a daily-use sunscreen option that minimizes irritation risk while promoting adherence to photoprotection.
Zitieren
APA
Gala, M. Y., Muchhala, S. S., Dhanaki, G. D., Sanghavi, A. P., & Kotak, B. P. (2026). Evaluation of the skin safety of a test product (sunscreen) for primary skin irritation using the skin irritation test (patch test in humans). Cosmoderma, 6, 39. https://doi.org/10.25259/csdm_10_2026
Vancouver
Gala MY, Muchhala SS, Dhanaki GD, Sanghavi AP, Kotak BP. Evaluation of the skin safety of a test product (sunscreen) for primary skin irritation using the skin irritation test (patch test in humans). Cosmoderma. 2026;6:39. doi:10.25259/csdm_10_2026
BibTeX
@article{Gala2026,
author = {Gala, Monil Yogesh and Muchhala, Snehal Sameer and Dhanaki, Gauri Debashish and Sanghavi, Arti Pradip and Kotak, Bhavesh Prabhudas},
title = {Evaluation of the skin safety of a test product (sunscreen) for primary skin irritation using the skin irritation test (patch test in humans)},
journal = {Cosmoderma},
year = {2026},
volume = {6},
pages = {39},
doi = {10.25259/csdm_10_2026}
}
EUVIMED